
Amryt Pharma Holdings Ltd
LSE:AMYT

Amryt Pharma Holdings Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?
What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?
Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.
Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.
Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.
What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?
What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?
Show all valuation multiples
for Amryt Pharma Holdings Ltd.
Provide P/S
for Amryt Pharma Holdings Ltd.
Provide P/E
for Amryt Pharma Holdings Ltd.
Provide P/OCF
for Amryt Pharma Holdings Ltd.
Provide P/FCFE
for Amryt Pharma Holdings Ltd.
Provide P/B
for Amryt Pharma Holdings Ltd.
Provide EV/S
for Amryt Pharma Holdings Ltd.
Provide EV/GP
for Amryt Pharma Holdings Ltd.
Provide EV/EBITDA
for Amryt Pharma Holdings Ltd.
Provide EV/EBIT
for Amryt Pharma Holdings Ltd.
Provide EV/OCF
for Amryt Pharma Holdings Ltd.
Provide EV/FCFF
for Amryt Pharma Holdings Ltd.
Provide EV/IC
for Amryt Pharma Holdings Ltd.
Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.
What are the Revenue projections
for Amryt Pharma Holdings Ltd?
How accurate were the past Revenue estimates
for Amryt Pharma Holdings Ltd?
What are the Net Income projections
for Amryt Pharma Holdings Ltd?
How accurate were the past Net Income estimates
for Amryt Pharma Holdings Ltd?
What are the EPS projections
for Amryt Pharma Holdings Ltd?
How accurate were the past EPS estimates
for Amryt Pharma Holdings Ltd?
What are the EBIT projections
for Amryt Pharma Holdings Ltd?
How accurate were the past EBIT estimates
for Amryt Pharma Holdings Ltd?
Compare the revenue forecasts
for Amryt Pharma Holdings Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Amryt Pharma Holdings Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Amryt Pharma Holdings Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Amryt Pharma Holdings Ltd compared to its peers.
Compare the P/E ratios
of Amryt Pharma Holdings Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Amryt Pharma Holdings Ltd with its peers.
Analyze the financial leverage
of Amryt Pharma Holdings Ltd compared to its main competitors.
Show all profitability ratios
for Amryt Pharma Holdings Ltd.
Provide ROE
for Amryt Pharma Holdings Ltd.
Provide ROA
for Amryt Pharma Holdings Ltd.
Provide ROIC
for Amryt Pharma Holdings Ltd.
Provide ROCE
for Amryt Pharma Holdings Ltd.
Provide Gross Margin
for Amryt Pharma Holdings Ltd.
Provide Operating Margin
for Amryt Pharma Holdings Ltd.
Provide Net Margin
for Amryt Pharma Holdings Ltd.
Provide FCF Margin
for Amryt Pharma Holdings Ltd.
Show all solvency ratios
for Amryt Pharma Holdings Ltd.
Provide D/E Ratio
for Amryt Pharma Holdings Ltd.
Provide D/A Ratio
for Amryt Pharma Holdings Ltd.
Provide Interest Coverage Ratio
for Amryt Pharma Holdings Ltd.
Provide Altman Z-Score Ratio
for Amryt Pharma Holdings Ltd.
Provide Quick Ratio
for Amryt Pharma Holdings Ltd.
Provide Current Ratio
for Amryt Pharma Holdings Ltd.
Provide Cash Ratio
for Amryt Pharma Holdings Ltd.
What is the historical Revenue growth
over the last 5 years for Amryt Pharma Holdings Ltd?
What is the historical Net Income growth
over the last 5 years for Amryt Pharma Holdings Ltd?
What is the current Free Cash Flow
of Amryt Pharma Holdings Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Amryt Pharma Holdings Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
UK |
![]() |
Amryt Pharma Holdings Ltd
LSE:AMYT
|
453.2m GBP | 362.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
765.9B USD | 37 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
399.9B USD | 13.5 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.2 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.3B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
180.7B CHF | 9.9 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.3B GBP | 131 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.5B USD | 9 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
138.2B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
UK |
![]() |
Amryt Pharma Holdings Ltd
LSE:AMYT
|
Average EV/EBITDA:
430.1
362.3
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
37
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.5
|
7%
|
1.9 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.2
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
9.9
|
5%
|
2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.